Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

13 trials with published results (5%)

Research Maturity

104 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.3%

3 terminated out of 237 trials

Success Rate

97.2%

+10.7% vs benchmark

Late-Stage Pipeline

13%

31 trials in Phase 3/4

Results Transparency

13%

13 of 104 completed with results

Key Signals

13 with results97% success

Data Visualizations

Phase Distribution

141Total
Not Applicable (71)
Early P 1 (1)
P 1 (21)
P 2 (17)
P 3 (11)
P 4 (20)

Trial Status

Completed104
Recruiting55
Unknown38
Not Yet Recruiting17
Active Not Recruiting10
Enrolling By Invitation7

Trial Success Rate

97.2%

Benchmark: 86.5%

Based on 104 completed trials

Clinical Trials (237)

Showing 20 of 20 trials
NCT05180110Completed

A Performance Evaluation of the LumiraDx Point of Care CRP Assay

NCT05699174Phase 3RecruitingPrimary

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

NCT05797246Phase 2Active Not Recruiting

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT07607470Not Yet Recruiting

Large Algorithm Setting and Validation Study

NCT00967785Phase 1Recruiting

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NCT00006150RecruitingPrimary

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

NCT07598006Completed

Hypervirulent Amoxicillin-Susceptible Klebsiella Pneumoniae CC66, France, 2016-2023

NCT05422326Phase 2Completed

A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

NCT06702878Phase 3Completed

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

NCT07189858Not ApplicableCompleted

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada

NCT07034573Completed

Evaluation of a Ventilation-filtration System for Operating Rooms at the Protestant Hospital of Mbouo (VENTI-MBOUO)

NCT05471973Not ApplicableRecruitingPrimary

CIED Infection Quality Initiative Demonstration Project

NCT05846438Not ApplicableRecruitingPrimary

Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.

NCT06092866Not ApplicableCompletedPrimary

Digital Versus Telephone Symptom Assessment and Triage in Primary Care

NCT05881447Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

NCT06116656TerminatedPrimary

Changes in Host Gene Expression to Differentiate Between Systemic Inflammation and Infection After Major Surgery

NCT07215871Phase 1Enrolling By Invitation

Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

NCT05568966Not ApplicableRecruiting

Collection of Blood Samples for New Diagnostic Devices 2

NCT05770622Phase 4Recruiting

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)

NCT06592586Phase 2Active Not Recruiting

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Scroll to load more

Research Network

Activity Timeline